Cargando…

Post-marketing surveillance in the published medical and grey literature for percutaneous transluminal coronary angioplasty catheters: a systematic review

BACKGROUND: Post-marketing surveillance (PMS) may identify rare serious incidents or adverse events due to the long-term use of a medical device, which was not captured in the pre-market process. Percutaneous transluminal coronary angioplasty (PTCA) is a non-surgical procedure that uses a balloon-ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Polisena, Julie, Forster, Alan J, Cimon, Karen, Rabb, Danielle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853687/
https://www.ncbi.nlm.nih.gov/pubmed/24112460
http://dx.doi.org/10.1186/2046-4053-2-94
_version_ 1782294672423518208
author Polisena, Julie
Forster, Alan J
Cimon, Karen
Rabb, Danielle
author_facet Polisena, Julie
Forster, Alan J
Cimon, Karen
Rabb, Danielle
author_sort Polisena, Julie
collection PubMed
description BACKGROUND: Post-marketing surveillance (PMS) may identify rare serious incidents or adverse events due to the long-term use of a medical device, which was not captured in the pre-market process. Percutaneous transluminal coronary angioplasty (PTCA) is a non-surgical procedure that uses a balloon-tipped catheter to enlarge a narrowed artery. In 2011, 1,942 adverse event reports related to the use of PTCA catheters were submitted to the FDA by the manufacturers, an increase from the 883 reported in 2008. The primary research objective is to conduct a systematic review of the published and grey literature published between 2007 and 2012 for the frequency of incidents, adverse events and malfunctions associated with the use of PTCA catheters in patients with coronary artery disease (CAD). Grey literature has not been commercially published. METHODS: We searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials and PubMed for medical literature on PMS for PTCA catheters in patients with CAD published between January 2007 and July 2012. We also searched the grey literature. RESULTS: This review included 11 studies. The in-hospital adverse events reported were individual cases of myocardial infarction and hematoma. In studies of patients with coronary perforation, more patients with balloon angioplasty were identified compared with patients who required stenting. CONCLUSIONS: Our systematic review illustrates that the volume and quality of PMS studies associated with the use of PTCA catheters in patients with CAD are low in the published and grey literature, and may not be useful sources of information for decisions on safety. In most studies, the objectives were not to monitor the long-term safety of the use of PTCA catheters in clinical practice. Future studies can explore the strengths and limitations of PMS databases administered by regulatory authorities.
format Online
Article
Text
id pubmed-3853687
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38536872013-12-07 Post-marketing surveillance in the published medical and grey literature for percutaneous transluminal coronary angioplasty catheters: a systematic review Polisena, Julie Forster, Alan J Cimon, Karen Rabb, Danielle Syst Rev Research BACKGROUND: Post-marketing surveillance (PMS) may identify rare serious incidents or adverse events due to the long-term use of a medical device, which was not captured in the pre-market process. Percutaneous transluminal coronary angioplasty (PTCA) is a non-surgical procedure that uses a balloon-tipped catheter to enlarge a narrowed artery. In 2011, 1,942 adverse event reports related to the use of PTCA catheters were submitted to the FDA by the manufacturers, an increase from the 883 reported in 2008. The primary research objective is to conduct a systematic review of the published and grey literature published between 2007 and 2012 for the frequency of incidents, adverse events and malfunctions associated with the use of PTCA catheters in patients with coronary artery disease (CAD). Grey literature has not been commercially published. METHODS: We searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials and PubMed for medical literature on PMS for PTCA catheters in patients with CAD published between January 2007 and July 2012. We also searched the grey literature. RESULTS: This review included 11 studies. The in-hospital adverse events reported were individual cases of myocardial infarction and hematoma. In studies of patients with coronary perforation, more patients with balloon angioplasty were identified compared with patients who required stenting. CONCLUSIONS: Our systematic review illustrates that the volume and quality of PMS studies associated with the use of PTCA catheters in patients with CAD are low in the published and grey literature, and may not be useful sources of information for decisions on safety. In most studies, the objectives were not to monitor the long-term safety of the use of PTCA catheters in clinical practice. Future studies can explore the strengths and limitations of PMS databases administered by regulatory authorities. BioMed Central 2013-10-10 /pmc/articles/PMC3853687/ /pubmed/24112460 http://dx.doi.org/10.1186/2046-4053-2-94 Text en Copyright © 2013 Polisena et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Polisena, Julie
Forster, Alan J
Cimon, Karen
Rabb, Danielle
Post-marketing surveillance in the published medical and grey literature for percutaneous transluminal coronary angioplasty catheters: a systematic review
title Post-marketing surveillance in the published medical and grey literature for percutaneous transluminal coronary angioplasty catheters: a systematic review
title_full Post-marketing surveillance in the published medical and grey literature for percutaneous transluminal coronary angioplasty catheters: a systematic review
title_fullStr Post-marketing surveillance in the published medical and grey literature for percutaneous transluminal coronary angioplasty catheters: a systematic review
title_full_unstemmed Post-marketing surveillance in the published medical and grey literature for percutaneous transluminal coronary angioplasty catheters: a systematic review
title_short Post-marketing surveillance in the published medical and grey literature for percutaneous transluminal coronary angioplasty catheters: a systematic review
title_sort post-marketing surveillance in the published medical and grey literature for percutaneous transluminal coronary angioplasty catheters: a systematic review
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853687/
https://www.ncbi.nlm.nih.gov/pubmed/24112460
http://dx.doi.org/10.1186/2046-4053-2-94
work_keys_str_mv AT polisenajulie postmarketingsurveillanceinthepublishedmedicalandgreyliteratureforpercutaneoustransluminalcoronaryangioplastycathetersasystematicreview
AT forsteralanj postmarketingsurveillanceinthepublishedmedicalandgreyliteratureforpercutaneoustransluminalcoronaryangioplastycathetersasystematicreview
AT cimonkaren postmarketingsurveillanceinthepublishedmedicalandgreyliteratureforpercutaneoustransluminalcoronaryangioplastycathetersasystematicreview
AT rabbdanielle postmarketingsurveillanceinthepublishedmedicalandgreyliteratureforpercutaneoustransluminalcoronaryangioplastycathetersasystematicreview